作者
Eugene Shenderov, Angelo Demarzo, Karim Boudadi, Mohamad Allaf, Hao Wang, Carolyn Chapman, Christian Pavlovich, Trinity Bivalacqua, Tanya Skelton O’Neal, Rana Harb
发表日期
2018/5/20
期刊
J. Clin. Oncol
卷号
36
期号
15
页码范围
10.1200
简介
To investigate whether Enoblituzumab mediated B7-H3 inhibition is safe, effective and immunologically active in the pre-surgical PCa setting by conducting a phase II neoadjuvant clinical trial in 32 men with high-risk localized PCa scheduled for prostatectomy
学术搜索中的文章
E Shenderov, A Demarzo, K Boudadi, M Allaf, H Wang… - J. Clin. Oncol, 2018